NO912168L - Fremgangsmaate for fremstilling av terapeutisk aktive piperazinderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive piperazinderivater.

Info

Publication number
NO912168L
NO912168L NO91912168A NO912168A NO912168L NO 912168 L NO912168 L NO 912168L NO 91912168 A NO91912168 A NO 91912168A NO 912168 A NO912168 A NO 912168A NO 912168 L NO912168 L NO 912168L
Authority
NO
Norway
Prior art keywords
group
denotes
formula
procedure
preparation
Prior art date
Application number
NO91912168A
Other languages
English (en)
Other versions
NO177931C (no
NO177931B (no
NO912168D0 (no
Inventor
Pascal George
Jacques Menin
Jean-Pierre Merly
Dennis Bigg
Daniel Obitz
Michel Peynot
Corinne Veronique
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO912168D0 publication Critical patent/NO912168D0/no
Publication of NO912168L publication Critical patent/NO912168L/no
Publication of NO177931B publication Critical patent/NO177931B/no
Publication of NO177931C publication Critical patent/NO177931C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO912168A 1990-06-07 1991-06-06 Analogifremgangsmåte for fremstilling av terapeutisk aktive piperazinderivater NO177931C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007067A FR2663026B1 (fr) 1990-06-07 1990-06-07 Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique.

Publications (4)

Publication Number Publication Date
NO912168D0 NO912168D0 (no) 1991-06-06
NO912168L true NO912168L (no) 1991-12-09
NO177931B NO177931B (no) 1995-09-11
NO177931C NO177931C (no) 1995-12-20

Family

ID=9397358

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912168A NO177931C (no) 1990-06-07 1991-06-06 Analogifremgangsmåte for fremstilling av terapeutisk aktive piperazinderivater

Country Status (21)

Country Link
US (1) US5192763A (no)
EP (1) EP0461012B1 (no)
JP (1) JPH04235958A (no)
KR (1) KR100188902B1 (no)
AT (1) ATE104662T1 (no)
AU (1) AU634391B2 (no)
CA (1) CA2043981A1 (no)
CS (1) CS173691A3 (no)
DE (1) DE69101740T2 (no)
DK (1) DK0461012T3 (no)
ES (1) ES2054460T3 (no)
FI (1) FI97055C (no)
FR (1) FR2663026B1 (no)
HU (1) HU209620B (no)
IE (1) IE64688B1 (no)
IL (1) IL98372A (no)
NO (1) NO177931C (no)
NZ (1) NZ238431A (no)
PL (1) PL165187B1 (no)
PT (1) PT97885B (no)
ZA (1) ZA914339B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245712B (it) * 1991-04-09 1994-10-14 Boehringer Mannheim Italia Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
FR2684374B1 (fr) * 1991-12-02 1995-05-19 Synthelabo Derives substitues de 1-[(1-arylpyrrolidin-2-yl)methyl]piperazine, leur preparation et leur application en therapeutique.
IT1255704B (it) * 1992-09-30 1995-11-10 Boehringer Mannheim Italia Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250771A (en) * 1962-12-17 1966-05-10 Geigy Chem Corp 5-monocarbocyclic aryl-n-lower alkyl-2-pyrrolidine carboxylic acid, esters, amides and derivatives thereof
GB1428493A (en) * 1973-05-02 1976-03-17 Science Union & Cie Heterocyclic amides processes for their preparation and pharma ceutical compositions containing them
US5063242A (en) * 1989-04-21 1991-11-05 Warner-Lambert Company 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents

Also Published As

Publication number Publication date
NO177931C (no) 1995-12-20
EP0461012B1 (fr) 1994-04-20
FI97055B (fi) 1996-06-28
PT97885B (pt) 1998-10-30
IE64688B1 (en) 1995-08-23
NZ238431A (en) 1992-09-25
CA2043981A1 (en) 1991-12-08
PT97885A (pt) 1992-03-31
KR920000751A (ko) 1992-01-29
AU7819691A (en) 1991-12-12
DE69101740T2 (de) 1994-10-20
DE69101740D1 (de) 1994-05-26
IL98372A (en) 1996-01-31
FI97055C (fi) 1996-10-10
KR100188902B1 (ko) 1999-06-01
HU911895D0 (en) 1991-12-30
ES2054460T3 (es) 1994-08-01
US5192763A (en) 1993-03-09
NO177931B (no) 1995-09-11
JPH04235958A (ja) 1992-08-25
PL165187B1 (pl) 1994-11-30
HUT58070A (en) 1992-01-28
PL290572A1 (en) 1992-02-10
FR2663026B1 (fr) 1992-08-07
ZA914339B (en) 1992-03-25
AU634391B2 (en) 1993-02-18
CS173691A3 (en) 1992-02-19
EP0461012A1 (fr) 1991-12-11
DK0461012T3 (da) 1994-09-12
ATE104662T1 (de) 1994-05-15
FR2663026A1 (fr) 1991-12-13
IE911941A1 (en) 1991-12-18
FI912733A (fi) 1991-12-08
FI912733A0 (fi) 1991-06-06
HU209620B (en) 1994-09-28
IL98372A0 (en) 1992-07-15
NO912168D0 (no) 1991-06-06

Similar Documents

Publication Publication Date Title
DE69716226T2 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
NO892058L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzamider.
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
NO158459C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutanderivater.
NO912168D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazinderivater.
IL61687A0 (en) Benzothiazole derivatives,pharmaceutical formulations containing them and a process for their preparation
ATE100103T1 (de) 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
ATE188700T1 (de) Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung
NO170274C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme benzhydryloksyetylpiperidin-derivater
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
SE8901060D0 (sv) New compounds
JPS57188566A (en) 2-(3-(3-indolyl)-2-amino-propionyloxy)acetic acid derivative, manufacture and medicine containing same
SE8302452D0 (sv) Method for treatment of senile dementia
NO171639C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
NO158462C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2)-kondenserte 1,4-benzodiazepinforbindelser.
FI921298A (fi) Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
NO167201C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive semikarbazid-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001